top of page
hook.png
Accurate Diagnosis

Develop early, accurate diagnostic methods and effective therapies for musculoskeletal disorders to improve patient outcomes.

3.png
attention_research_1.jpg
Transformer-Based Models 
A transformer-based model for DMD MRI analysis can effectively capture spatial and contextual patterns across varying field strengths to enable accurate, robust disease detection and progression monitoring.
Automated Metrics Extraction

Precise measurement of muscle volume, fat fraction, and T2 relaxation times for comprehensive analysis.

1-s2.0-S2214031X23000530-ga1_lrg.jpg

Low Field MRI & AI

Why MRI over other diagnostic tools?

Muscle biopsy is invasive and takes a long time to analyze. Genetic testing is expensive and faces skepticism from the public. Low-field MRI (less than 1 Tesla) is a non-invasive, cheaper, and faster alternative. Whether it's leveraging advanced AI technology for detailed tissue analysis or opting for cost-effective, non-invasive methods, this table highlights the key features and benefits of each approach, ensuring optimal patient care and effective monitoring of muscle conditions.

Integrating artificial intelligence (AI) with low-field MRI (LF MRI) systems offers a revolutionary approach to diagnostic imaging, combining cost-effectiveness with advanced technological capabilities.

Artificial Intelligence

Low-field MRI is affordable, making advanced imaging accessible in resource-limited settings, reducing healthcare costs and increasing patient care frequency.

Timely Results

AI-enhanced LF MRI delivers quick image processing and analysis, enabling faster diagnosis and treatment planning for improved patient outcomes.

Accuracy

AI improves LF MRI accuracy by enhancing image quality, providing reliable diagnostic information crucial for detecting and monitoring conditions.

non-invasiveness

LF MRI is non-invasive and safe, using no ionizing radiation, allowing repeated imaging for continuous monitoring without additional risk.

1.png

Call 

+421 902 950 910

Email 

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

©2023 mMEDCON.

bottom of page